CDH2 and cancer: The exact mechanism by which inversin could increase cancer invasion is at its infancy, however, modulating the epithelial–mesenchymal transition (EMT) by impairing E-cadherin expression and upregulating N-cadherin and Vimentin is a possible mechanism [29].